Zimbabwe has turned down a major US health deal valued at $367m (272 million pounds) spanning five years because of the United States' request for confidential data.
This rejection came to light following a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman later stated that the US was requesting health data for research and commercial purposes while was unwilling to share the benefits from any future vaccines.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to find a agreement agreeable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Background
This development follows a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were raised about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our citizens if a future disease outbreak emerge."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining structures already established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future collaboration might be structured in a way that honours the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body said it understood the official position, but recommended that negotiations must proceed given that much of the country's Aids initiatives depended on external financing.
"If specific concerns arise, including those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," it commented.
The halted deal emphasises the ongoing challenges between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.